Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: Insights from the APEX-AMI trial

Kurt Huber, David R. Holmes, Arnoud W. Van 'T Hof, Gilles Montalescot, Philip E. Aylward, G. Amadeo Betriu, Petr Widimsky, Cynthia M. Westerhout, Christopher B. Granger, Paul W. Armstrong

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: Insights from the APEX-AMI trial'. Together they form a unique fingerprint.

Medicine & Life Sciences